Final Trades: Gold, Nike, Humana & more
The "Halftime Report" traders give their top picks to watch for the second half.
Humana Sets Succession For Retiring CEO Bruce Broussard
Health insurer Humana announced a succession plan for long-time chief executive officer Bruce Broussard who will retire next year and be replaced by Jim Rechtin, the current CEO of Envision Healthc...
Insurer Humana's longtime CEO Broussard to step down next year
Humana CEO Bruce Broussard will step down in the second half of 2024 after more than a decade at the helm, the insurer said on Wednesday and named healthcare veteran Jim Rechtin as his successor.
Humana (HUM) Surpasses Market Returns: Some Facts Worth Knowing
Humana (HUM) concluded the recent trading session at $501.54, signifying a +0.68% move from its prior day's close.
Humana: Bullish Rating Thanks To Strong Financials And Low Valuation
Humana gets a Buy rating, agreeing with the bullish consensus from analysts, Wall Street, and the quant system. Bullish sentiment fueled by low valuation, cheap share price, dividend stability, pro...
Humana (HUM) Boosts Healthcare Choices for MA Members in Denver
Humana (HUM) enters into a deal with Denver Health to expand its local provider network across the Denver area as well as offer greater care access to its Medicare Advantage members of the region.
Here's Why Investors Should Retain Humana (HUM) Stock Now
Humana (HUM) benefits from an upgraded health plan offering suite, expanding Medicare Advantage membership and solid cash reserves.
Humana's (HUM) 2024 MA Plans Promise a Wider Set of Benefits
Humana (HUM) aims to expand the reach of its Medicare plans across newer U.S. counties in 2024 through integrating multiple lucrative benefits within them.
Humana: Buy This Amazing Wealth Compounder Now, You'll Be Glad You Did
Humana's adjusted diluted EPS and free cash flow payout ratios make the dividend very secure. The managed care company's revenue and adjusted diluted EPS both surged in the first half of 2023. Huma...
Buy the Dip: 3 Healthcare Stocks to Snag Now for Supercharged Gains
In the ever-evolving landscape of investing, the spotlight is on the top healthcare stocks to buy on the dip. The healthcare sector is highly known for its robust resilience and incredible growth p...
Here's Why Investors Should Hold Humana (HUM) in Portfolio
Humana (HUM) remains well-poised for growth on the back of an expanding Medicare Advantage membership, upgraded health plan offering suite and solid cash reserves.
Humana (HUM) to Provide In-home Care With Primary Care Anywhere
Humana (HUM) enhances its CenterWell brand with the launch of Primary Care Anywhere.
A Quality Executive Compensation Plan Lowers The Risk Of Investing In Humana
Humana (HUM) is the featured stock in August's Exec Comp Aligned with ROIC Model Portfolio.
Humana (HUM) to Bring Enhanced Kidney Care to MA Members
Humana (HUM) makes Interwell's extensive resources available to its MA members grappling with CKD and ESKD, and hence bring about better health outcomes for them.
Should You Buy This Blue Chip Dividend Stock?
Humana's revenue and earnings jumped in the second quarter. The company's small dividend has exceptional growth potential.
Related Companies